About Icahn School of Medicine | Icahn School of Medicine

Revolutionizing Education and Research

We pioneer what’s possible in patient care by weaving research, empathy, and education into everything we do – with groundbreaking results.

State of the School 2023

Dean Charney provides an overview of the School’s accomplishments in research, education, patient care, diversity, and more.

The Emotional Faces Memory Task in Rejoyn

Based on technology developed by Mount Sinai and licensed to Click Therapeutics

About the School

Located in the heart of New York City, the Icahn School of Medicine at Mount Sinai is an international leader in biomedical education, research, and patient care. It is the medical school for the Mount Sinai Health System, which includes eight hospital campuses. With over 7,000 faculty, 1,200 students, and 2,500 residents and fellows, we are propelled by cutting-edge technology, breakthrough research, and multidisciplinary teamwork. Our advances arise from a willingness to challenge conventional wisdom, and together we make big, bold bets, producing dramatically better outcomes for our patients.

Explore Icahn

Welcome to the Forefront of Transformational Healthcare

Search By

All

All
Education Programs
Faculty & Researchers
Research Institutes, Centers, Programs & Labs

Search Query

We Are Shaping Tomorrow

The future of medicine is changed one student, one professor, one patient, one researcher, and one study at a time. Here are our stories.

“Capturing Life” as a Future Doctor, Influencer, and Photographer

Meet psychiatry resident Biobele Braide, MD

Miriam Merad Image

Icahn Mount Sinai Immunologist Elected to National Academy of Medicine

Read about Miriam Merad, MD, PhD

Aimee Lucas, MD, Appointed New Site Chief of Gastroenterology & Hepatology

Learn More

Michael F. Murray

Mount Sinai Welcomes New System Chief of Genomic Medicine

Meet Michael F. Murray, MD

Icahn Researcher Receives Prestigious American Diabetes Association Award

Celebrate Carol Levy’s, MD, successes

Serotonin Receptors

Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits

Crohns Disease infographic

Mount Sinai Researchers the First to Apply Single-Cell Analysis to Reveal Mechanisms of a Common Complication of Crohn’s Disease

Resources For You

Mount Sinai Ideas Network

Diversity, Equity, and Inclusion

Faculty Policies and Resources

Contact Icahn Mount Sinai

Mount Sinai Podcasts

Icahn Mount Sinai Videos